INTRODUCTION
Inflammatory Myofibroblastic Tumour (IMT) defines a histologically distinctive lesion with uncertain behavior and denotes a pseudosarcomatous inflammatory lesion that contains spindle cells, myofibroblasts, plasma cells, lymphocytes and histiocytes. 1 Its biological behavior varies from frequently benign lesions to more aggressive variants. IMT occurs commonly in the lung. Extrapulmonary IMT in children have been described in the mesentery, omentum, liver, bladder, mediastinum, head and neck, extremities, appendix, and kidneys, with the largest tumours occuring in the abdomen and retroperitoneum. 2 Retroperitoneum is a rare site. Calcifications too are rare and confuse this tumor with another distinctive entity calcific fibrous pseudotumour. CFPs have some distinct characteristics which differentiate them from IMTs, though some believe them to be a late sclerozing stage of IMT. 3 IMT frequently recurs and rarely metastasizes 1 . Best proven modality of treatment is surgery.
1 Anti-inflammatory drugs in children have been suggested and chemotherapy for indolent cases has been tried but without documented success. 4, 5 
CASE REPORT
A 3 year old female child presented to us with abdominal pain, intermittent fever and gradually progressive abdominal mass of 1 year duration. She was taking treatment with her local practitioner for urinary tract infection. On examination a hard mass was palpated in the right lumbar region which was fixed to the psoas muscle. Plain X-ray of abdomen showed a calcific round mass in the right lumbar region. Ultrsonography and CT scan revealed a right sided retroperitoneal mass of 8.5 cm x 6.5 cm x 5 cm. with calcifications. Kidney was displaced supero-laterally. Tumour was abutting the inferior vena cava and was buried in the psoas muscle. Aspiration cytology was inconclusive. Surgery was performed. Part of the tumour adherent to the inferior vena cava infero-medially could not be resected. Histopathology reported, inflammatory myofibroblastic tumor of retroperitoneum with calcification. Tumor cells were positive for desmin, vimentin and actin. Post operatively patient was put on steroid therapy and ultrasound done 3 months later showed no evidence of tumour. Follow up is planned with CT scan for recurrence and subsequent tapering of steroids. 
DISCUSSION
Inflammatory myofibroblastic tumour was first described by Brunn in 1939. 6 The histopathological definition of an IMT is a distinctive neoplasm composed of myofibroblastic mesenchymal spindle cells accompanied by an inflammatory infiltrate of plasma cells. 7 Tissue samples obtained by fine-needle or tru-cut biopsies, and even analysis of perioperative biopsies, are not enough to establish a diagnosis. The pathologist usually asks for the whole specimen. 1, 8 In our case, FNAC was inconclusive. Our final diagnosis was only possible after the evaluation of the whole mass and the detection of neoplastic growth of myofibroblastic spindle cells on an inflammatory background with dystrophic calcifications. Currently, surgery is the mainstay of treatment for IMTs. 1, 8 Complete removal of the tumour generally provides resolution of all symptoms. However, tumours in intra or retroperitoneal locations tend to invade adjacent structures, preventing curative resections and breeding local recurrences. 8 In our case, visible residual tissue was left behind. Unfortunately, chemotherapy and radiotherapy are not successful in most patients. 2, 9. Recently, researchers have published promising results with anti-inflammatory agents and anti-tumour necrosis factor-α binding antibodies. 2, 9 . Additionally, Berger and colleagues 9 reported the first case of a bladder inflammatory myofibroblastic tumour that responded to an anti-inflammatory regimen (prednisone and Cox-2 inhibitor) even before surgical extirpation.
Calcifying Fibrous Pseudotumor (CFP) is another distinct entity characterized by a predominantly lymphoplasmacytic infiltrate with abundant hyalinized collagen and psammomatous or dystrophic calcifications. These lesions were reported initially as "childhood fibrous pseudotumor with psammoma bodies". 10 The term "calcifying fibrous pseudotumor" was coined by Fetsch et al. in 1993. 4 The cause and pathogenesis are unclear, but it has been postulated that CFP may 3 Simple excision with a margin of normal tissue is the treatment of choice. The risk for local recurrence is low. 3 Both IMT and CFP were initially considered to be lesions of young children. Fetsch et al. 4 described the occurrence of CFP in patients between 1 and 33 years of age (mean age, 16.2 years), with a slight predilection for females. CFP usually presents as a mass in an otherwise healthy patient; whereas IMT patients may have other symptoms or signs such as fever, pain, weight loss, malaise, anemia, thrombocytosis, increased sedimentation rate, and hypergammaglobulinemia. 11 Distinction from IMT may be difficult because; spindle cells, an inflammatory infiltrate, and sometimes calcifications characterize both CFP and IMT. Coffin et al. 7, 11 documented IMTs associated with local recurrence. In contrast, CFP has an excellent prognosis, with recurrences being rare. 10 The spindle cells of IMT react intensely against antibodies for muscle-specific actin and desmin, which points to the myofibroblastic nature of the cells. Kalisha et al. 10 in their study have reported that none of the CFPs stained with muscle-specific actin, smooth muscle actin, or desmin.For clarifications, we reproduce the tabular comparision between these two entities studied extensively by Kalisha et al. In our patient the main confusion was with CFP. The clinical symptoms of mass with fever, earlier presumed to be urinary infection was a clue which was not taken preoperatively, which abated post-operatively. Histopathology confirmed calcific IMT with positive staining for muscle specific actin, smooth muscle actin and desmin. The residual tumour in view of retroperitoneal location and histopathology of IMT was treated with anti-inflammatory treatment in the form of steroids, to avoid local recurrence of the tumour.
CONCLUSION
IMTs are rare tumours with distinct histopathology. Retroperitoneal location of this tumor is also rare. Rarer still are calcifications in IMT. In the reported case, the presence of calcification led to the confusion of a neuroblastoma or CFP, pre-operatively. Final histopathology confirmed an IMT with calcification. The CFPs have features including their biological behavior and prognosis distinct from IMTs. Some CFPs may have similar features with IMTs, and it is important to separate those cases in children, especially those arising from the soft tissue and those occurring in the retroperitoneum. Tissue biopsy is essential along with immunohistochemical studies to confirm the diagnosis. IMTs frequently recur, but rarely metastasize. In residual tumors further follow up could be with anti-inflammatory drugs to preventive inoperable recurrences.
